The startup is developing “modified DNA” therapies it claims can combine the strengths of multiple approaches, from messenger ...
Serif Biomedicines has emerged from stealth with $50 million in start-up funding. The new firm is developing what it calls ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results